title: [Kidney and bone update : the 5-year history and future of CKD-MBD. Vascular calcification in CKD patients].
abstract: The one of the main concept of CKD-MBD theory is to prevent and to retard progression of vascular calcification. Recently many basic researches have approached to clear the mechanism of uremic specific vascular calcification. However it remains unclear in clinical setting what examination is best for evaluating vascular calcification. Moreover it is still not sure whether the management based on guidelines can prevent progression of vascular calcification or not in CKD patients. We review about the most accessible clinical factors for vascular calcification.
authors: Division of Nephrology, TOHO University Ohashi Medical Center, Japan.
authors: Nobuhiko
authors: N
authors: Joki
authors: Masaki
authors: M
authors: Iwasaki
mesh_terms: D001851:Bone Diseases, Metabolic / Q000150:complications* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002219:Carbamates / Q000008:administration & dosage; D002614:Chelating Agents / Q000008:administration & dosage; D002908:Chronic Disease; D018450:Disease Progression; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000378:metabolism; D008903:Minerals / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000378:metabolism; D010758:Phosphorus / Q000378:metabolism; D016226:Phosphorus, Dietary / Q000008:administration & dosage; D011073:Polyamines / Q000008:administration & dosage; D011379:Prognosis; D000069603:Sevelamer; D061205:Vascular Calcification / Q000209:etiology* / Q000517:prevention & control*; D014807:Vitamin D / Q000008:administration & dosage
chemical_list: D002219:Carbamates; D002614:Chelating Agents; D008903:Minerals; D010281:Parathyroid Hormone; D016226:Phosphorus, Dietary; D011073:Polyamines; D014807:Vitamin D; D010758:Phosphorus; D000069603:Sevelamer; C070766:carbamic acid; D002118:Calcium